Duodenal ulcer disease

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 8, 1996, Pages 829-833

  Tytgat, Guido N J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotic regimen; Duodenal ulcer; Helicobacter pylori

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH; CLARITHROMYCIN; METRONIDAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE; TINIDAZOLE; VIRULENCE FACTOR;

BLEEDING; DUODENUM ULCER; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; PATHOGENESIS; PEPTIC ULCER; PRIORITY JOURNAL; RECURRENT PEPTIC ULCER; SHORT SURVEY; STOMACH ACID SECRETION; STOMACH ULCER;

ANTI-BACTERIAL AGENTS; DUODENAL ULCER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 0029835750     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (44)

1. Tytgat GNJ, Noach LA, Rauws EAJ: Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am 1993, 22:127-140.
2. Tytgat GNJ, Lee A, Graham DY, Dixon MF, Rokkas T: The role of infectious agents in peptic ulcer disease. Gastroenterol Intern 1993, 6:76-89.
3. Tytgat GNJ, Dixon MF: Role of Helicobacter pylori in the pathogenesis of peptic ulcer disease: practical implications for the clinician. In Proton Pump Inhibitors and Acid Related Disorders. Edited by Hunt RH. Auckland: Adis International; 1994:72-97.
4. Bayerdorffer E, Lehn N, Hatz R, et al.: Differences in expression of Helicobacter pylori gastritis in antrum and body. Gastroenterology 1992, 102:1575-1582.
5. Dixon MF: Recent advances in gastritis. Curr Diagn Pathol 1994, 1:80-89.
6. Dixon MF: Pathophysiology of Helicobacter pylori infection. Scand J Gastroenterol 1994, 29(suppl. 201):7-10.
7. Lee A, Dixon MF, Danon SJ, et al.: Local acid production and Helicobacter pylori: a unifying hypothesis of gastroduodenal disease. Eur J Gastroenterol Hepatol 1995, 7:461-465.
8. Cover TL, Blaser MJ: Helicobacter pylori: a bacterial cause of gastritis, peptic ulcer disease and gastric cancer. ASM News 1995, 61:21-26.
9. Xiang Z, Censini S, Beyeli PF, et al.: Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995, 63:94-8.
10. Weel JFL, Van der Hulst RWM, Gerrits Y, et al.: The interrelation between cytotoxin associated gene A, vacuolating cytotoxin and Helicobacter pylori related disease. J Infect Dis 1996, 173:1171-1175.
11. Crabtree JE, Farmery SM, Lindley, et al.: CagA/cytotoxic strains of Helicobacter pylori and interleukin 8 in gastric epithelial cell lines. J Clin Pathol 1994, 47:945-950.
12. Boren T, Falk P, Roth KA, Larson G, Normark S: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens. Science 1993, 262:1892-1895.
13. Moss S, Legon S, Bishop A, Polak JM, Calam J: Effect of Helicobacter pylori on gastric somatostatin in duodenal ulcer disease. Lancet 1992, 340:930-932.
14. Graham DY, Go MF: Helicobacter pylori: current status. Gastroenterology 1993, 105:279-282.
15. Peterson WL, Barnett CC, Evans DJ Jr, et al.: Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pylori. Am J Gastroenterol 1993, 88:2038-2043.
16. Rapier RC, Dreilinger AD, Nijberg LM, et al.: Helicobacter pylori diminishes proximal duodenal mucosal bicarbonate secretion in patients with duodenal ulcer disease. Gastroenterology 1994, 106:A164.
17. Rabeneck L, Ransohoff DF: Is Helicobacter pylori a cause of duodenal ulcer? A methodologic critique of current evidence. Am J Med 1991, 91:566-572.
18. Sipponen P, Varis K, Fraki O, et al.: Cumulative 10 year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. Scand J Gastroenterol 1990, 25:966-973.
19. Cullen DJE, Collins BJ, Christiansen KJ, et al.: Long-term risk of peptic ulcer disease in people with Helicobacter pylori infection: a community based study. Gut 1993, 34(suppl. 1):F284.
20. Niemelà S, Karttunen T, Kerola T: Helicobacter pylori-associated gastritis. Evolution of histologic changes over 10 years. Scand J Gastroenterol 1995, 30:542-549.
21. Rauws EAJ, Tytgat GNJ: Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990, 335:1233-1235.
22. Tytgat GNJ: Treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol 1994, 8:359-368.
23. Rauws EAJ, Tytgat GNJ: Helicobacter pylori in duodenal and gastric ulcer disease. Baillière Clin Gastroenterol 1995 9(3).
24. NIH Consensus Development Panel: Helicobacter pylori in peptic ulcer disease. JAMA 1994, 272:65-69.
25. Labenz J, Börsch G: Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection. Am J Gastroenterol 1994, 89:1785-1788.
26. Forbes GM, Glaser ME, Cullen DJE, Warren JR, Christiansen KL, Marshall BJ, et al.: Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up. Lancet 1994, 343:258-260.
27. Langenberg W, Rauws EAJ, Widjojokusumo A, Tytgat GNJ, Zanen HC: Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol 1986, 24:414-417.
28. Xia HX, Windle HJ, Marshall DG, Smyth CJ, Keane CT, O'Morain CA: Recrudescence of Helicobacter pylori after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting. Gut 1995, 37:30-34.
29. Tytgat GNJ, Noach LA: H. pylori eradication. In Helicobacter pylori. Basic Mechanisms to Clinical Cure. Edited by Hunt RH, Tytgat GNJ. Dordrecht/Boston/London: Kluwer Academic Publishers; 1994:550-569.
30. Van der Hulst RWM, Keller JJ, Tytgat GNJ: Treatment of H. pylori infection in man: review of the world literature. Helicobacter 1996, 1:6-19.
31. De Boer WA, Tytgat GNJ: The best therapy for Helicobacter pylori infection: should efficacy or side effect profile determine our choice? Scand J Gastroenterol 1995, 30:401-417.
32. Hosking SW, Lin TKW, Chung SCS, Yung MY, Cheng AFB, Sung JJ, et al.: Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomized controlled trial. Lancet 1994, 343:508-510.
33. El-Omar E, Penman T, Dorrian CA, Ardill JES, McColl KEL: Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer. Gut 1993, 34:1060-1065.
34. McColl KEL, El-Nujumi AM, Chittajallu RS, et al.: A study of the pathogenesis of Helicobacter negative chronic duodenal ulceration. Gut 1993, 34:762-768.
35. Hosking SW, Yung MY, Chung SC, Li AKL: Differing prevalence of Helicobacter in bleeding and non bleeding ulcers. Gastroenterology 1992, 102:A85.
36. Reinbach DH, Cruickshank G, McColl EL: Acute perforated duodenal ulcer is not associated with Helicobacter pylori infection. Gut 1993, 34:1344-1347.
37. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saled JA: Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993, 28:939-942.
38. Labenz J, Börsch G: Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994, 55:19-23.
39. Rokkas T, Karamesis A, Maurogeorgis A, et al.: Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995, 41:1-4.
40. Jaspersen D, Koerner T, Schors W, et al.: Helicobacter pylori eradication reduces the rate of rebleeding in ulcer hemorrhage. Gastrointest Endosc 1995, 41:5-7.
41. Soll AH, Weinstein WM, Kurata J, McCarthy D: Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 1995, 114:307-319.
42. Jensen DM, Cheng S, Kovacs TOG, et al.: A controlled study of ranitidine for the prevention of recurrent hemorrhage from duodenal ulcer. N Engl J Med 1994, 330:382-386.
43. George LL, Borody TJ, Andrews P, Devine M, Moore-Jones D, Walton M, et al.: Cure of duodenal ulcer after eradication of Helicobacter pylori. Med J Aust 1990, 153:145-149.
44. O'Connor H: Eradication of H. pylori, therapies and clinical complications. Postgrad Med J 1992, 68:549-557.